Get the Stockscreener App
91.85
1.87%
-1.75
After Hours:
91.53
-0.32
-0.35%
Disc Medicine Inc stock is traded at $91.85, with a volume of 515.59K.
It is down -1.87% in the last 24 hours and up +6.78% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$93.60
Open:
$92.95
24h Volume:
515.59K
Relative Volume:
1.03
Market Cap:
$3.47B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-25.03
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
-1.51%
1M Performance:
+6.78%
6M Performance:
+74.26%
1Y Performance:
+42.91%
1-Day Range:
$91.52
$94.50
1-Week Range:
$89.86
$99.50
52-Week Range:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
91.85 | 3.53B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance
Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application - MSN
Discipline and Rules-Based Execution in IRON Response - news.stocktradersdaily.com
Disc Medicine (IRON): Reassessing Valuation After Encouraging RALLY-MF Phase 2 Anemia Data - simplywall.st
H.C. Wainwright reiterates Buy rating on Disc Medicine stock By Investing.com - Investing.com Canada
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Finviz
Disc Medicine stock price target raised to $115 by Leerink on MF anemia data - Investing.com Canada
Disc Medicine (NASDAQ:IRON) Sets New 12-Month HighTime to Buy? - MarketBeat
ASH: Disc Set for Busy 2026 After Promising Interim Anemia Drug Data - Citeline News & Insights
Disc Medicine Inc stock hits 52-week high at 97.63 USD - Investing.com
Disc Medicine stock price target raised to $117 by Raymond James on trial data - Investing.com UK
Disc Medicine Advances Bitopertin in FDA Pilot Program - TipRanks
Disc Medicine, Inc. Reviews ASH Meeting Data and Operational Plans - TradingView
Disc Medicine (NASDAQ:IRON) Builds Momentum In Clinical Science - Kalkine Media
IRON Stock Boosted by Positive Phase 2 Trial Results of DISC-097 - GuruFocus
Transcript : Disc Medicine, Inc.Special Call - marketscreener.com
Bollard Group LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine reveals encouraging Phase 2 data at ASH event - Traders Union
Disc Medicine reports positive data from DISC-0974 anemia trial - Investing.com
Disc Medicine Presents Positive Initial Data from RALLY-MF - GlobeNewswire
IRONAI Stock Analysis - Meyka
Saturn V Capital Management LP Sells 122,062 Shares of Disc Medicine, Inc. $IRON - MarketBeat
How Disc Medicine Inc. stock trades before earningsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Disc Medicine Earnings Notes - Trefis
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Disc Medicine, Inc. $IRON Shares Acquired by Sio Capital Management LLC - MarketBeat
Is Disc Medicine Inc. stock positioned well for digital economy2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Disc Medicine (IRON) Stock Analysis Report | Financials & Insights - Benzinga
JPMorgan Chase & Co. Grows Position in Disc Medicine, Inc. $IRON - MarketBeat
Analysis Recap: How Disc Medicine Inc stock trades before earnings2025 EndofYear Setup & Free Verified High Yield Trade Plans - BỘ NỘI VỤ
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Geode Capital Management LLC Purchases 26,605 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Behavioral Patterns of IRON and Institutional Flows - news.stocktradersdaily.com
DNB Asset Management AS Takes $243,000 Position in Disc Medicine, Inc. $IRON - MarketBeat
Is Disc Medicine Inc. stock attractive for hedge fundsRecession Risk & Expert Curated Trade Ideas - BỘ NỘI VỤ
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - AOL.com
Ensign Peak Advisors Inc Purchases 69,032 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Disc Medicine stock hits 52-week high at 96.09 USD By Investing.com - Investing.com Nigeria
Disc Medicine stock hits 52-week high at 96.09 USD - Investing.com
FY2025 EPS Estimate for Disc Medicine Decreased by Analyst - MarketBeat
Disc Medicine Inc. (IRON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Disc Medicine Inc. stock performs in high volatility marketsGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Jefferies reiterates Buy rating on Disc Medicine stock ahead of key catalysts - Investing.com Canada
What technical charts say about Disc Medicine Inc. stockWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Disc Medicine Inc. stock attractive for passive investorsGap Up & Weekly High Conviction Ideas - newser.com
How sustainable is Disc Medicine Inc. stock dividend payout2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Disc Medicine Inc. stock momentum explainedPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):